FLGT News and Press, Fulgent Genetics Inc. From 04/10/25

Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its first quarter 2025 financial results bef...

2025-04-04 14:30:59 ET Summary In March, we welcomed 30 new analysts to Seeking Alpha, and in this article we are showcasing their stock picks and investment strategies. Our analysts covered a diverse set of industries—including IT, financials, utilities, materials, and min...

2025-03-20 14:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2025-03-20 05:46:16 ET Summary CFO bought 1.5 million worth on March 5th, a Price/Book ratio of 0.43x and a Net Current Assets Value (NCAV) of 0.68x that day. Now it's trading at 0.47x Price/Book Value and 0.72x NCAV, showing a significant undervaluation. However, nothing is c...

2025-03-10 07:54:47 ET More on Ryman Hospitality Properties Ryman Hospitality Properties, Inc. (RHP) Q4 2024 Earnings Call Transcript Seeking Alpha’s Quant Rating on Ryman Hospitality Properties Historical earnings data for Ryman Hospitality Properties ...

2025-03-10 07:54:00 ET Summary The market was down 3.1% for the week and down 2.9% YTD. We are now back to where we started on election day in November 2024. The best performer last week was Volatility, which should surprise no one. The worst performer was the small cap Russell 20...

DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P M...

2025-02-28 11:57:31 ET Fulgent Genetics, Inc. (FLGT) Q4 2024 Earnings Conference Call February 27, 2025, 08:30 AM ET Company Participants Melanie Solomon - IR Ming Hsieh - Chairman and CEO Brandon Perthuis - Chief Commercial Officer Paul Kim - CFO Confe...

2025-02-28 07:02:54 ET More on Fulgent Genetics Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside Fulgent Genetics: A Value Stock With Caveats (Rating Downgrade) Seeking Alpha’s Quant Rating on Fulgent Genetics Historical earnings dat...

Full Year Total Revenue of $283.5 million Full Year Core Revenue grows 7% year-over-year to $281.2 million Ended 2024 with $828.6 million of cash, cash equivalents, restricted cash, and investments in marketable securities, representing cash per share of $26.87 Fulgent Genetic...